Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Apr 3, 2006
Clinical News
Exenatide LAR update
Read More
BioCentury
|
Aug 29, 2005
Clinical News
Exenatide LAR: Preliminary Phase II data
Read More
BioCentury
|
Nov 1, 2004
Product Development
GLP-1 pipeline
Read More
BioCentury
|
Apr 19, 2004
Product Development
Clock watching
Read More
BioCentury
|
Apr 5, 2004
Clinical News
Exenatide LAR: Phase II started
Read More
BioCentury
|
Mar 24, 2003
Clinical News
Exenatide LAR: Phase II
Read More
BioCentury
|
Jan 6, 2003
Finance
Upcoming milestones
Read More
BioCentury
|
Jul 8, 2002
Product Development
Alkermes pipeline
Read More
BioCentury
|
Jul 1, 2002
Clinical News
AC2993 LAR: AMLN started a double-blind, placebo-controlled U.S. Phase II trial of AC2993 LAR in up to 100 patients to treat Type II diabetes. AC2993 LAR uses M
Read More
BioCentury
|
Jun 25, 2002
Clinical News
Amylin starts long-acting AC2993 Phase II
Read More
Items per page:
10
1 - 10 of 13
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help